Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
Netwerk
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
-
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities
Spanjaart, A. M., Pennings, E. R. A., Kos, M., Mutsaers, P. G. N. J., Lugtenburg, P. J., Van Meerten, T., Van Doesum, J. A., Minnema, M. C., Jak, M., Van Dorp, S., Vermaat, J. S. P., Van Der Poel, M. W. M., Van Oijen, M. G. H., Kuipers, M. T., Nijhof, I. S. & Kersten, M. J., 1-mrt.-2023, In: JCO oncology practice. 19, 3, blz. E407-E416Onderzoeksoutput › Academic › peer review
Open AccessBestand2 Downloads (Pure) -
High frequency of hyperglycaemia observed during CAR T-cell treatment
Tienstra, M., de Boer, J. W., van Doesum, J. A., van Meerten, T. & van Dijk, P. R., feb.-2023, In: Diabetic Medicine. 40, 2, 2 blz.Onderzoeksoutput: Letter › Academic › peer review
Open AccessBestand4 Downloads (Pure) -
Semi-automated 18F-FDG PET segmentation methods for tumor volume determination in Non-Hodgkin lymphoma patients: a literature review, implementation and multi-threshold evaluation
Keijzer, K., Niezink, A. G. H., de Boer, J. W., van Doesum, J. A., Noordzij, W., van Meerten, T. & van Dijk, L. V., 20-jan.-2023, In: Computational and Structural Biotechnology Journal. 21, blz. 1102-1114 13 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand17 Downloads (Pure) -
Antibody Response in Immunocompromised Patients with Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19
Haggenburg, S., Hofsink, Q., Lissenberg-Witte, B. I., Broers, A. E. C., Van Doesum, J. A., Van Binnendijk, R. S., Den Hartog, G., Bhoekhan, M. S., Haverkate, N. J. E., Burger, J. A., Bouhuijs, J. H., Smits, G. P., Wouters, D., Van Leeuwen, E. M. M., Bontkes, H. J., Kootstra, N. A., Zweegman, S., Kater, A. P., Heemskerk, M. H. M., Groen, K., & 8 anderen, okt.-2022, In: JAMA oncology. 8, 10, blz. 1477-1483 7 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand16 Citaten (Scopus)8 Downloads (Pure) -
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
All ZUMA-7 Investigators Contribut, Locke, F. L., Miklos, D. B., Jacobson, C. A., Perales, M-A., Kersten, M-J., Oluwole, O. O., Ghobadi, A., Rapoport, A. P., McGuirk, J., Pagel, J. M., Munoz, J., Farooq, U., van Meerten, T., Reagan, P. M., Sureda, A., Flinn, I. W., Vandenberghe, P., Song, K. W., Dickinson, M., & 12 anderen, 7-feb.-2022, In: New England Journal of Medicine. 386, blz. 640-654 15 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand242 Citaten (Scopus)80 Downloads (Pure)
Activiteiten
- 1 Supervision and examination of PhD students of the UG
-
R. Bouwstra; Innate immune checkpoint inhibitors for treatment of diffuse large B-cell lymphoma
Jon Daniel Laman (Member of PhD Examining Committee), Edwin Bremer (Supervisor), Gerwin Huls (Supervisor) & Tom van Meerten (Co-supervisor)
21-sep.-2022Activiteit: Supervision and examination of PhD students of the UG › Academic
Datasets
-
Additional file 1 of DSP107 combines inhibition of CD47/SIRPα axis with activation of 4-1BB to trigger anticancer immunity
Tabakman, R. (Contributor), Cendrowicz, E. (Contributor), Pecker, I. (Contributor), Gozlan, Y. (Contributor), Kahn, R. (Contributor), Dranitzki, M. E. (Contributor), Tamir, A. (Contributor), Tamir, L. (Contributor), Jacob, L. (Contributor), van Meerten, T. (Contributor), Avichzer, J. (Contributor), Peled, A. (Contributor), Aronin, A. (Contributor), Amsili, S. (Contributor), Vlaming, M. (Contributor), Huls, G. (Contributor), Foley-Comer, A. (Contributor), Chajut, A. (Contributor), Zorde-Khvalevsky, E. (Contributor), Pereg, Y. (Contributor), Greenwald, S. (Contributor), Ghantous, L. (Contributor) & Bremer, E. (Contributor), figshare Academic Research System, 15-mrt.-2022
DOI: 10.6084/m9.figshare.19359964.v1, https://springernature.figshare.com/articles/dataset/Additional_file_1_of_DSP107_combines_inhibition_of_CD47_SIRP_axis_with_activation_of_4-1BB_to_trigger_anticancer_immunity/19359964/1
Dataset
Knipsels
-
Axi-cel CAR-T significantly improves EFS among older patients with non-Hodgkin lymphoma
16/02/2022
1 item van Media-aandacht
Pers / media: Onderzoek › Popular
-
-
UMCG gaat zelf medicijn tegen lymfeklierkanker maken
26/09/2021
1 Mediabijdrage
Pers / media: Overig › Popular
-
Podcast De Genezers over CAR T-celtherapie
05/06/2021
1 item van Media-aandacht
Pers / media: Expert Comment › Popular
-
€ 30 miljoen subsidie voor UMCG-onderzoek naar veelbelovende kankerbehandeling
24/09/2020
1 Mediabijdrage
Pers / media: Overig › Popular